DCAF17
DDB1- and CUL4-associated factor 17
Also known as: C2orf37, DCA17_HUMAN, FLJ13096
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5H9S7
- Gene
- DCAF17
- Ensembl
- ENSG00000115827
- Chromosome
- 2
- Canonical length
- 520 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a nuclear transmembrane protein that associates with cullin 4A/damaged DNA binding protein 1 ubiquitin ligase complex. Mutations in this gene are associated with Woodhouse-Sakati syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
Canonical amino-acid sequenceUniProt
520 residues, UniProt reviewed canonical sequence.
>Q5H9S7|DCAF17
1 MGPTRKPNVC SRLSRRALGC FSRDAGVVQR TNLGILRALV CQESTKFKNV WTTHSRSPIA
61 YERGRIYFDN YRRCVSSVAS EPRKLYEMPK CSKSEKIEDA LLWECPVGDI LPNSSDYKSS
121 LIALTAHNWL LRISATTGKI LEKIYLAPYC KFRYLSWDTP QEVIAVKSAQ NRGSAVARQA
181 GIQQHVLLYL AVFRVLPFSL VGILEINKKI FGNVTDATLS HGILIVMYSS GLVRLYSFQT
241 IAEQFMQQKL DLGCACRWGG TTGTVGEAPF GIPCNIKITD MPPLLFEVSS LENAFQIGGH
301 PWHYIVTPNK KKQKGVFHIC ALKDNSLAKN GIQEMDCCSL ESDWIYFHPD ASGRIIHVGP
361 NQVKVLKLTE IENNSSQHQI SEDFVILANR ENHKNENVLT VTASGRVVKK SFNLLDDDPE
421 QETFKIVDYE DELDLLSVVA VTQIDAEGKA HLDFHCNEYG TLLKSIPLVE SWDVTYSHEV
481 YFDRDLVLHI EQKPNRVFSC YVYQMICDTG EEEETINRSCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DCAF17 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- retina: 13 nTPM
- thyroid gland: 9.5 nTPM
- thymus: 7.3 nTPM
- lymph node: 6.8 nTPM
- skin: 6.8 nTPM
- ovary: 6.1 nTPM
Single-cell type
- oligodendrocytes: 65 nCPM
- thyrotrophs: 45 nCPM
- myonuclei: 45 nCPM
- somatotrophs: 43 nCPM
- adrenal cortex cells: 38 nCPM
- microglia: 38 nCPM
Immune cell
- MAIT T-cell: 3.4 nTPM
- naive CD8 T-cell: 2.5 nTPM
- gdT-cell: 2.3 nTPM
- naive CD4 T-cell: 2 nTPM
- memory CD4 T-cell: 1.8 nTPM
- naive B-cell: 1.8 nTPM
Brain region
- white matter: 22 nTPM
- thalamus: 15 nTPM
- cerebellum: 15 nTPM
- basal ganglia: 15 nTPM
- cerebral cortex: 14 nTPM
- medulla oblongata: 13 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DCAF17.
Disease | AllUniProt
Conditions DCAF17 is implicated in, by any mechanism.
- Woodhouse-Sakati syndrome (WDSKS) MIM:241080
Disease | GeneticClinVar
57 pathogenic / likely-pathogenic of 589 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Woodhouse-Sakati syndrome
- Neurodegeneration with brain iron accumulation
- DCAF17-related disorder
- Papillary renal cell carcinoma type 1
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.82
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.82
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- DDB1- and CUL4-associated factor 17
- DDB1- and CUL4-associated factor 17
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DCAF17 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DCAF17 as an antibody target. Whether an autoantibody or antibody against DCAF17 could matter depends on whether native DCAF17 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DCAF17 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DCAF17 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...